{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:47:24Z","timestamp":1790117244176,"version":"4.0.1"},"reference-count":41,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Plovdiv","award":["HO-11\/2013"],"award-info":[{"award-number":["HO-11\/2013"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Rheumatoid arthritis (RA) is an inflammatory autoimmune disease with articular and systemic manifestations, and one of the most common is anemia. This study aims to investigate whether the levels of the soluble receptors sRAGE, sRANKL, and OPG are affected by the distribution of RA patients in subgroups according to soluble transferrin receptor\/log ferritin (sTfR-F index) and hemoglobin (Hb) levels and to examine their correlation with indicators of iron metabolism, disease activity, and autoimmune and inflammatory changes. The levels of sRANKL and sRAGE were significantly higher in the subgroup of anemia of chronic disease combined with iron deficiency anemia (ACD\/IDA) compared to the ACD group: p &lt; 0.0001 and p &lt; 0.0001. The level of OPG tended to decrease in ACD\/IDA (p = 0.053). sRAGE was positively correlated with prohepcidin, RF and anti-CCP antibodies, sRANKL, CRP, and IL-6 only in the ACD group. A negative correlation was found between sRAGE, sRANKL, and serum iron only in the ACD\/IDA group. sRANKL was positively correlated with OPG, prohepcidin, CRP, IL-6, RF, anti-CCP antibodies, and DAS28 only in the ACD group. Positive correlations were observed between OPG and ferritin, sTfR, CRP, IL-6, RF, and DAS28, and a negative correlation was observed with serum iron only in the ACD group. Therefore, the investigated soluble receptors may serve as reliable biomarkers involved in the pathogenesis of RA and may contribute to the identification of patients at risk of developing combined anemia.<\/jats:p>","DOI":"10.3390\/ijms252312729","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T04:20:12Z","timestamp":1732681212000},"page":"12729","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Are the Soluble Receptors sRAGE, sRANKL, and Osteoprotegerin Associated with Anemia in Rheumatoid Arthritis?"],"prefix":"10.3390","volume":"25","author":[{"given":"Katya","family":"Stefanova","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Pharmacy, Medical University of Plovdiv, 15A Vasil Aprilov Blvd., 4002 Plovdiv, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5520-0590","authenticated-orcid":false,"given":"Ginka","family":"Delcheva","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Pharmacy, Medical University of Plovdiv, 15A Vasil Aprilov Blvd., 4002 Plovdiv, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9520-1758","authenticated-orcid":false,"given":"Teodora","family":"Stankova","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Pharmacy, Medical University of Plovdiv, 15A Vasil Aprilov Blvd., 4002 Plovdiv, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11010-022-04492-3","article-title":"Rheumatoid arthritis: Advances in treatment strategies","volume":"478","author":"Prasad","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13075-022-02955-y","article-title":"The effect of targeted rheumatoid arthritis therapeutics on systemic inflammation and anemia: Analysis of data from the CorEvitas RA registry","volume":"24","author":"Padula","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Mitrovi\u0107, J., Hrka\u010d, S., Te\u010der, J., Golob, M., Ljilja Posavec, A., Kolar Mitrovi\u0107, H., and Grgurevi\u0107, L. (2023). Pathogenesis of Extraarticular Manifestations in Rheumatoid Arthritis\u2014A Comprehensive Review. Biomedicines, 11.","DOI":"10.3390\/biomedicines11051262"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/ard.55.3.162","article-title":"Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset","volume":"55","author":"Peeters","year":"1996","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/ar4323","article-title":"Comparative evaluation of the effects of treatment with tocilizumab and TNF-alpha inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients","volume":"15","author":"Song","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s10067-019-04873-y","article-title":"Inflammatory anemia may be an indicator for predicting disease activity and structural damage in Chinese patients with rheumatoid arthritis","volume":"39","author":"Chen","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.5114\/aoms\/172443","article-title":"Anemia in elderly rheumatoid arthritis patients: A cohort study","volume":"20","author":"Sun","year":"2024","journal-title":"Arch. Med. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.amjmed.2003.12.012","article-title":"Prevalence and outcomes of anemia in rheumatoid arthritis: A systematic review of the literature","volume":"116","author":"Wilson","year":"2004","journal-title":"Am. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.4081\/hr.2019.7708","article-title":"Studying Anemia of Chronic Disease and Iron De-ficiency in Patients with Rheumatoid Arthritis by Iron Status and Circulating Hepcidin","volume":"11","author":"Khalaf","year":"2019","journal-title":"Hematol. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/ajh.22108","article-title":"Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: A prospective multicenter evaluation of soluble transferrin receptor and the sTfR\/log ferritin index","volume":"86","author":"Skikne","year":"2011","journal-title":"Am. J. Hematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jbspin.2010.05.017","article-title":"Rheumatoid anemia","volume":"78","author":"Masson","year":"2011","journal-title":"Jt. Bone Spine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1874312901913010009","article-title":"The value of soluble transferrin receptor and soluble transferrin receptor-ferritin index in discriminating iron deficiency anaemia from anaemia of chronic disease in patients with rheumatoid arthritis","volume":"13","year":"2019","journal-title":"Open Rheumatol. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/pgmj.2011.117507","article-title":"Anaemia in rheumatoid arthritis: Can we afford to ignore it?","volume":"87","author":"Bloxham","year":"2011","journal-title":"Postgrad. Med. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/annrheumdis-2012-202709","article-title":"Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: A prospective cohort study","volume":"73","author":"Scherer","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/annrheumdis-2013-203718","article-title":"Anaemia to predict radiographic progression in rheumatoid arthritis","volume":"72","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_16","first-page":"560","article-title":"Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: Evidence from the CORRONA registry","volume":"27","author":"Furst","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_17","first-page":"2177","article-title":"Association of anemia and physical disability among patients with rheumatoid arthritis","volume":"34","author":"Han","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","article-title":"Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-\u03ba\u0392 ligand: Modulation of the expression by osteotropic factors and cytokines","volume":"275","author":"Nakashima","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","article-title":"Involvement of receptor activator of nuclear factor kappa \u0392 ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis","volume":"43","author":"Takayanagi","year":"2000","journal-title":"Arthritis Rheum."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: A novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI200114002","article-title":"The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses","volume":"108","author":"Schmidt","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1681\/ASN.V1351296","article-title":"Receptor for advanced glycation end products on human synovial fibroblasts: Role in the pathogenesis of dialysis-related amyloidosis","volume":"13","author":"Hou","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00296-004-0456-y","article-title":"Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis","volume":"25","author":"Drinda","year":"2005","journal-title":"Rheumatol. Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"37525","DOI":"10.1074\/jbc.M111.223438","article-title":"Solution structure of the soluble receptor for advanced glycation end products (sRAGE)","volume":"286","author":"Ikonen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1042\/bj20021371","article-title":"Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury","volume":"370","author":"Yonekura","year":"2003","journal-title":"Biochem. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2174\/092986706777585013","article-title":"Soluble receptor for advanced glycation end products: From disease marker to potential therapeutic target","volume":"13","author":"Geroldi","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/ar2645","article-title":"Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis","volume":"11","author":"Chen","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1002\/art.22217","article-title":"Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1","volume":"54","author":"Pullerits","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.4049\/jimmunol.0903398","article-title":"sRAGE induces human monocyte survival and differentiation","volume":"185","author":"Wang","year":"2010","journal-title":"J. Immunol."},{"key":"ref_33","first-page":"1238","article-title":"sRANKL, OPG and sRAGE as markers of bone metabolism in rheumatoid arthritis: Relation to indicators of impaired iron homeostasis and inflammation","volume":"74","author":"Stefanova","year":"2021","journal-title":"Comptes Rendus L\u2019acad\u00e9mie Bulg. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Delcheva, G., Stefanova, K., and Stankova, T. (2023). Serum sRAGE, sRANKL and osteoprotegerin in subgroups of rheumatoid arthritis patients: Biomarkers associated with iron and disease status. Biotechnol. Biotechnol. Equip., 37.","DOI":"10.1080\/13102818.2023.2256428"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/rheumatology\/kep329","article-title":"Therapeutic targets in rheumatoid arthritis: The interleukin-6 receptor","volume":"49","author":"Dayer","year":"2010","journal-title":"Rheumatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1210\/js.2019-00160","article-title":"Advanced glycation end products (AGEs), receptor for AGEs, diabetes, and bone: Review of the literature","volume":"10","author":"Asadipooya","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejr.2014.06.001","article-title":"Serum levels of osteoprotegerin and RANKL in patients with rheumatoid arthritis and their relation to bone mineral density and disease activity","volume":"37","author":"Fadda","year":"2015","journal-title":"Egypt. Rheumatol."},{"key":"ref_38","first-page":"10","article-title":"Osteoprotegerin serum levels in rheumatoid arthritis","volume":"10","author":"Kolarz","year":"2003","journal-title":"J. Miner. Muskuloskelettale Erkrank."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1515\/CCLM.2005.056","article-title":"Soluble transferring receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis","volume":"43","author":"Margetic","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/0377-4929.40417","article-title":"Serum transferrin receptor ferritin index shows concomitant iron deficiency anemia and anemia of chronic disease is common in patients with rheumatoid arthritis in north India","volume":"51","author":"Goyal","year":"2008","journal-title":"Indian. J. Pathol. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3899\/jrheum.110339","article-title":"Serum hepcidin: A direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis","volume":"38","author":"Essa","year":"2011","journal-title":"J. Rheumatol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/23\/12729\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:40:15Z","timestamp":1760114415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/23\/12729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":41,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["ijms252312729"],"URL":"https:\/\/doi.org\/10.3390\/ijms252312729","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}